Dr. Piervincenzi was previously a partner and leader in McKinsey & Company's Global Pharmaceutical and Medical Products Practice for 12 years where, among other responsibilities, he launched McKinsey's global drug safety, medical and regulatory service line. Dr. Piervincenzi earned his M.S. and Ph.D. from Duke University in Biomedical Engineering with research focused on protein engineering.
Outgoing CEO Roger L. Williams, M.D. oversaw an unprecedented period of growth for USP. During Dr. Williams’ tenure USP transformed from being an important standard setting organization to a recognized authority in global health through the establishment of facilities in Africa, China, India, Brazil and Europe.